Friday, November 24, 2017

Posts tagged with the keyword: ‘nasdaq oxgn’

Three Small Cap Biotechs Primed For Corrections Following ASCO

Three Small Cap Biotechs Primed For Corrections Following ASCO

The month of May has thus far been a very profitable one for investors in a number of small cap biotechs leading up to the June 2011 ASCO meeting, particularly ones that haven’t consequently fared too well once their respective binary events had met its endpoints. First up on the list is Oxigene, Inc. (NASDAQ:OXGN), […]

Oxigene Nears Marketing Approval of First Anaplastic Thyroid Cancer Drug

Oxigene Nears Marketing Approval of First Anaplastic Thyroid Cancer Drug

With just a few weeks left on the calendar before the world’s largest oncology annual meeting, investors are already gearing up their portfolios for equities that could see exponential gains based on their potentially new research abstracts. The American Society of Clinical Oncology (ASCO) will begin on June 3rd and will feature everything from investigational […]

Back to Top

Social Media Profiles

ADVERTISEMENT

BUSINESS NETWORKS

The New York Times logo CNN logo ABC logo CNBC logo